217 related articles for article (PubMed ID: 3954821)
1. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
Di Francesco GF; Baldoli E; Marchetti G; Glässer A
Arzneimittelforschung; 1986; 36(1):84-8. PubMed ID: 3954821
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Baldoli E; Bianchi G; Corsico N; Di Francesco GF
Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M
Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
[TBL] [Abstract][Full Text] [Related]
4. [Effect of prostaglandin Bl on systemic and regional hemodynamics].
Ismailov ShI; Flerov EV
Biull Eksp Biol Med; 1977 Feb; 83(2):131-3. PubMed ID: 851612
[TBL] [Abstract][Full Text] [Related]
5. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
6. [Effect of prostaglandin F2alpha on the systemic and regional hemodynamics of dogs].
Flerov EV; Ismailov ShI
Farmakol Toksikol; 1977; 40(1):44-50. PubMed ID: 852545
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs.
Dorigotti L; Ferni G; Lombroso M; Semeraro C
Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375
[TBL] [Abstract][Full Text] [Related]
8. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
9. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
Kawashima S; Liang CS
J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
[TBL] [Abstract][Full Text] [Related]
10. Effects of papaveroline-monosulphate on the systemic and regional circulation in the dog.
Data PG; Rolfo A; Cacchio M; Di Tano G
Farmaco Sci; 1981 Apr; 36(4):302-14. PubMed ID: 7250364
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC
J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786
[TBL] [Abstract][Full Text] [Related]
12. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Baumann G; Ningel K; Permanetter B
J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
[TBL] [Abstract][Full Text] [Related]
15. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
16. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.
Leather HA; Ver Eycken K; Segers P; Herijgers P; Vandermeersch E; Wouters PF
Crit Care Med; 2003 Sep; 31(9):2339-43. PubMed ID: 14501965
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine.
De Ponti C; Bardi U; Marchetti M
Arzneimittelforschung; 1976; 26(11):2089-92. PubMed ID: 1037254
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
[TBL] [Abstract][Full Text] [Related]
20. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
Bolt GR; Saxena PR
J Pharmacol Exp Ther; 1984 Jul; 230(1):205-13. PubMed ID: 6747826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
